SCHEMBL28299679

SCHEMBL28299679

Cc1cc(-c2ccccc2)n(-c2ccccc2-c2ccc(O)c(Cl)c2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
ESR2 Q92731 1/20 0.47
ALDH1A1 P00352 4/20 0.43
PTGS2 P35354 2/20 0.43
HPGD P15428 2/20 0.43
ADORA2A P29274 3/20 0.42
ADORA1 P30542 2/20 0.42
ALOX5 P09917 1/20 0.41
MARS1 P56192 2/20 0.40
PRKCZ Q05513 1/20 0.40
MAPT P10636 2/20 0.39
FABP3 P05413 1/20 0.39
FABP4 P15090 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
RECQL P46063 1/20 0.39
TP53 P04637 1/20 0.38
KDM4E B2RXH2 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28299534 0.89 NPC1 (0.52) NPC1RAB9AALDH1A1PTGS2HPGD
SCHEMBL28299561 0.85 NPC1 (0.49) NPC1RAB9AALDH1A1PTGS2HPGD
SCHEMBL28301090 0.83 TUBB4A (0.49) NPC1RAB9APTGS2ADORA2AADORA1
SCHEMBL28299665 0.83 NPC1 (0.55) NPC1RAB9AESR2ALDH1A1PTGS2
SCHEMBL28847563 0.81 NPC1 (0.44) NPC1RAB9AALDH1A1PTGS2HPGD
SCHEMBL29707615 0.79 NPC1 (0.63) NPC1RAB9AALDH1A1PTGS2HPGD
SCHEMBL3676529 0.79 NPC1 (0.63) NPC1RAB9AALDH1A1PTGS2HPGD
SCHEMBL28299743 0.76 RAB9A (0.53) NPC1RAB9AALDH1A1PTGS2HPGD
SCHEMBL28299787 0.74 NPC1 (0.47) NPC1RAB9AALDH1A1PTGS2HPGD
SCHEMBL12361456 0.71 RXRA (0.52) NPC1RAB9AALDH1A1PTGS2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109890822-A INHIBITORS OF CELLULAR METABOLIC PROCESSES 安吉奥斯医药品有限公司 2019-06-14 CN disclosed